Aurobindo

…

…

As we celebrate 75 years of India’s independence, another exceptional event calls our attention—the 150th birth anniversary of Sri Aurobindo, the revolutionary turned mystic, the supramental sage. Addressing this…

Drugmaker Aurobindo Pharma reported first-quarter consolidated net profit slid more than 32% to ₹520.3 crore. The net profit declined on an almost 9% increase in net sales to ₹6,176.8 crore (₹5,691.8 crore). Total income at ₹6,276.5 crore…

Shares of . fell 0.05 per cent to Rs 551.95 in Friday's session as of 12:40PM (IST) even as the equity benchmark Sensex traded 22.14 points higher at 53438.29. Earlier in the day, the stock witnessed a gap down start to the session. The…

Shares of . traded 1.35 per cent down at Rs 551.7 on Thursday at around 12:43PM (IST), while the benchmark BSE Sensex declined 35.9 points to 53478.25. As many as 27,309 shares changed hands on the counter with a total value of Rs 1.52…

Prabhudas Lilladher has accumulate call on . with a target price of Rs 635. The current market price of Aurobindo Pharma is Rs 544.2. Time period given by analyst is one year when Ltd. price can reach defined target. Aurobindo Pharma Ltd.,…

has abandoned proposed sale of Eugia Pharma Specialities – which could have been the largest deal for an injectables business in India at $3-4 billion – due to valuation differences with potential buyers, multiple people privy to the…

Shares of . traded 0.62 per cent up at Rs 515.05 at around 12:17PM (IST) on Thursday. The stock had closed at Rs 518.25 in the previous session. Equity benchmark Sensex traded 351.34 points higher at 52173.87 around the same time. The…

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement…